The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of cyclophosphamide (CY), GVAX, pembrolizumab (Pembro), and stereotactic body radiation (SBRT) in patients (pts) with locally advanced pancreas cancer (LAPC).
 
Valerie Lee
Research Funding - Merck; Novartis
 
Ding Ding
No Relationships to Disclose
 
Christina Rodriguez
No Relationships to Disclose
 
Beth Onners
No Relationships to Disclose
 
Amol Narang
Research Funding - Boston Scientific
 
Jeffrey Meyer
Honoraria - Springer; UpToDate
Research Funding - Boston Scientific (Inst)
 
Joseph M. Herman
Honoraria - Sirtex Medical
Travel, Accommodations, Expenses - Varian Medical Systems; Varian Medical Systems
 
Amy Hacker-Prietz
No Relationships to Disclose
 
Richard A. Burkhart
No Relationships to Disclose
 
William Burns
No Relationships to Disclose
 
Jin He
No Relationships to Disclose
 
Ana De Jesus-Acosta
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Rachel B. Klein
No Relationships to Disclose
 
Dan Laheru
No Relationships to Disclose
 
Dung T. Le
Stock and Other Ownership Interests - Seagen
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Merck
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Curegenix; Medivir; Merck; Nouscom (Inst)
Patents, Royalties, Other Intellectual Property - Inventor of technology, "Microsatellite Instability as a Pharmacogenomic Marker of Therapeutic Response to Immune Checkpoint Inhibition".
 
Amy Ryan
Honoraria - NCCN
 
Elizabeth Sugar
No Relationships to Disclose
 
Lei Zheng
Stock and Other Ownership Interests - Z and L International Medical
Consulting or Advisory Role - Alphamab; Ambrx; AstraZeneca; Biosynergies; Coherent; DataRevive; Foundation Medicine; Johnson & Johnson/Janssen; Merck; Merrimack; Mingruizhiyao; NovaGenesis; novarock
Research Funding - Amgen; AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb; Gradalis; Halozyme; InxMed; ITeos Therapeutics; Merck; NovaRock
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.